MANNKIND CORPORATION AND U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of March 4, 2021 2.50% Convertible Senior Notes due 2026Indenture • March 5th, 2021 • Mannkind Corp • Pharmaceutical preparations • New York
INDENTURE dated as of March 4, 2021 between MANNKIND CORPORATION, a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01) and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
AMENDMENT NO. 6 TO CREDIT AND SECURITY AGREEMENTCredit and Security Agreement • March 5th, 2021 • Mannkind Corp • Pharmaceutical preparations • New York
This AMENDMENT NO. 6 TO CREDIT AND SECURITY AGREEMENT (this “Agreement”) is made as of this 1st day of March, 2021, by and among MANNKIND CORPORATION, a Delaware corporation (“MannKind”), MANNKIND LLC, a Delaware limited liability company (“MannKind LLC”), QRUMPHARMA, INC., a Delaware corporation (“QP”, and, QP, together with MannKind and MannKind LLC, each a “Borrower” and collectively, the “Borrowers”), MIDCAP FINANCIAL TRUST, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
